2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
CNS
6
Genitourinary
3
Other
2
Lymphoid
2
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Lymphoma
2982
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2499
Lymphoma, Non-Hodgkin
2268
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Lymphoma, Follicular
1847
Lymphoma, Large B-Cell, Diffuse
1785
Leukemia
1341
Hodgkin Disease
1293
Lymphoma, Mantle-Cell
1193
Leukemia, Myeloid, Acute
979
Burkitt Lymphoma
956
Multiple Myeloma
866
Lymphoma, B-Cell, Marginal Zone
853
Recurrence
841
Lymphoma, B-Cell
756
Myelodysplastic Syndromes
683
Neoplasms
595
Lymphoma, T-Cell, Cutaneous
543
Waldenstrom Macroglobulinemia
514
Lymphoma, Large-Cell, Immunoblastic
490
Mycosis Fungoides
438
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
414
Lymphoma, Large-Cell, Anaplastic
390
Sezary Syndrome
364
Lymphoma, T-Cell, Peripheral
352
Hematologic Neoplasms
351
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
334
Myeloproliferative Disorders
328
Neoplasms, Plasma Cell
309
Blast Crisis
284
Interventions
Injections
1
Clopidogrel
1
Aspirin
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Ischemic Stroke
×
Lymphoid
×
Clear all
NCT05507645
2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3
Completed
1,446 enrolled
NCT03222024
2020-10-28
SIS
West China Hospital
Completed
2,500 enrolled